EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals

Christopher A Legare, Wesley M Raup-Konsavage, Kent E Vrana

Pharmacology · 2022 · 107 (3-4) · 131-149

DOI: 10.1159/000521683 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology, online erschienen am 28.01.2022. Verfasst von Christopher A Legare und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania, USA. Hauptthemen laut MEDLINE: Cannabidiol, Cannabinoids, Cannabis, Medical Marijuana. Die Arbeit wurde bisher 264-mal zitiert (Crossref) und nennt 138 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: There is a growing interest in the use of cannabis (and its extracts), as well as CBD oil (hemp extracts containing cannabidiol), for therapeutic purposes. While there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited objective data supporting the use of crude materials (CBD oil, cannabis extracts, and/or cannabis itself). Summary: In the present review, we examined data for pure cannabinoid compounds (dronabinol, nabilone, and CBD), as well as partially purified medicinal cannabis extracts (nabiximols), to provide guidance on the potential therapeutic uses of high-THC cannabis and CBD oil. In general, data support a role for cannabis/cannabinoids in pain, seizure disorders, appetite stimulation, muscle spasticity, and treatment of nausea/vomiting. Given the biological activities of the cannabinoids, there may be utility in treatment of central nervous system disorders (such as neurodegenerative diseases, PTSD, and addiction) or for the treatment of cancer. However, those data are much less compelling. Key Message: On balance, there are reasons to support the potential use of medical cannabis and cannabis extract (Δ9-THC-dominant or CBD-dominant), but much more careful research is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolCannabinoidsCannabisMedical MarijuanaCannabinoid Receptor Agonists

Stichwörter der Autor:innen

CBDCannabinoidsCannabisMedical marijuanaPharmacologyTherapeuticsΔ9-THC

Substanzen

Cannabinoid Receptor AgonistsCannabinoidsMedical MarijuanaCannabidiol

Autor:innen und Institutionen

  • Department of Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania, USA.

Zitieren

APA

Legare, C. A., Raup-Konsavage, W. M., & Vrana, K. E. (2022). Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. Pharmacology, 107(3-4), 131-149. https://doi.org/10.1159/000521683

Vancouver

Legare CA, Raup-Konsavage WM, Vrana KE. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. Pharmacology. 2022;107(3-4):131-149. doi:10.1159/000521683

BibTeX
@article{Legare2022,
  author = {Legare, Christopher A and Raup-Konsavage, Wesley M and Vrana, Kent E},
  title = {Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals},
  journal = {Pharmacology},
  year = {2022},
  volume = {107},
  number = {3-4},
  pages = {131--149},
  doi = {10.1159/000521683}
}
Kostenlos starten →